August 2026
1. AHMAD R, Zakirullah, Li M, Tong Y, et al
   Characterization, lytic activity, and therapeutic efficacy of a novel phage, BUCT789, lysing drug-resistant Escherichia coli in Galleria mellonella larvae.
   Virology. 2026;621:110956.
   

   >> Share

   
   July 2026
2. RODEA M GE, Gonzalez-Villalobos E, Espinoza-Mellado MDR, Morales-Garcia MR, et al
   Genomic characterization of a new member of the Phikmvvirus genus infecting multidrug-resistant high-risk clones of Pseudomonas aeruginosa.
   Virology. 2026;620:110775.
   

   >> Share

   
   March 2026
3. RAMUTH M, Sonoo J, Pyndiah N, Rughooputh S, et al
   Epidemiology of influenza A and B viruses in Mauritius over an 8-year period, 2009-2016.
   Virology. 2026;619:110892.
   

   >> Share

   
   February 2026
4. LI M, Guo R, Qi Z, Liu Y, et al
   Antibacterial activity of single Klebsiella phage and phage cocktail against clinical carbapenem-resistant Klebsiella pneumoniae in vitro.
   Virology. 2026;618:110840.
   

   >> Share

   
   October 2025
5. KIM SG
   Targeting bacterial persistence with bacteriophages: a next-generation antimicrobial strategy.
   Virology. 2025;611:110649.
   

   >> Share

   
   September 2025
6. EL-TELBANY M, Yamamura K, Saito N, Masuda Y, et al
   Characterization of phage vB_EfS_C1 and investigation of antibacterial and antibiofilm properties against vancomycin-susceptible and vancomycin-resistant Enterococcus faecium.
   Virology. 2025;612:110685.
   

   >> Share

   
   
7. GHOSH S, Pradhan S, Ghosh K
   Mini-review: Insight of bacteriophage therapy in clinical practice.
   Virology. 2025;610:110583.
   

   >> Share

   
   
8. ELSHAMY AA, Kamal SK, Mahmoud MT, Elhasany AM, et al
   Genomic analysis and preclinical evaluation of two hydrogel-formulated novel virulent phages isolated against a carbapenem-resistant Acinetobacter baumannii.
   Virology. 2025;612:110676.
   

   >> Share

   
   August 2025
9. APIRATWARRASAKUL S, Sresuwadjarey P, Phumthanakorn N, Withatanung P, et al
   The broad-spectrum kayvirus phage disrupts biofilms formed by methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius.
   Virology. 2025;611:110657.
   

   >> Share

   
   
10. CALERO-CACERES W, Balcazar JL
    Progress in phage therapy in response to antimicrobial resistance.
    Virology. 2025;609:110578.
    

    >> Share

    
    July 2025
11. CHENCHULA S, Atal S, Ghanta MK, Uppugunduri CR, et al
    Emerging variants of Mpox virus and tecovirimat resistance: Genomic insights and implications for treatment strategies.
    Virology. 2025;608:110532.
    

    >> Share

    
    March 2025
12. ZHANG C, Liu P, Li J, Han M, et al
    Adaptation of single molecule real time (SMRT) sequence technology for hepatitis C virus genome sequencing and identification of resistance-associated substitutions.
    Virology. 2025;605:110481.
    

    >> Share

    
    February 2025
13. LIN P, Liu S, Cao Z, Zeng Y, et al
    An experimental study on the lytic bacteriophage MSP15 with wide-spectrum targeting methicillin-resistant Staphylococcus aureus.
    Virology. 2025;605:110452.
    

    >> Share

    
    December 2024
14. NUWAGABA J, Li JA, Ngo B, Sutton RE, et al
    30 years of HIV therapy: Current and future antiviral drug targets.
    Virology. 2024;603:110362.
    

    >> Share

    
    
15. KUMAR N, Sharma S, Kumar R, Meena VK, et al
    Evolution of drug resistance against antiviral agents that target cellular factors.
    Virology. 2024;600:110239.
    

    >> Share

    
    November 2024
16. COSTA P, Pereira C, Romalde JL, Almeida A, et al
    A game of resistance: War between bacteria and phages and how phage cocktails can be the solution.
    Virology. 2024;599:110209.
    

    >> Share

    
    October 2024
17. LI Y, Zhang Y, Li A, Zhang T, et al
    Characterization of a novel lytic phage against methicillin resistance Staphylococcus aureus in Hainan island.
    Virology. 2024;600:110264.
    

    >> Share

    
    
18. FABIANI M, Castro EF, Battini L, Rosas RA, et al
    Two thiosemicarbazones derived from 1-indanone as potent non-nucleoside inhibitors of bovine viral diarrhea virus of different genotypes and biotypes.
    Virology. 2024;598:110189.
    

    >> Share

    
    July 2024
19. ZHANG Y, Shao Y, You H, Shen Y, et al
    Characterization and therapeutic potential of MRABP9, a novel lytic bacteriophage infecting multidrug-resistant Acinetobacter baumannii clinical strains.
    Virology. 2024;595:110098.
    

    >> Share

    
    December 2023
20. BIALY D, Richardson S, Chrzastek K, Bhat S, et al
    Recombinant A(H6N1)-H274Y avian influenza virus with dual drug resistance does not require permissive mutations to retain the replicative fitness in vitro and in ovo.
    Virology. 2023;590:109954.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share